# US 2003/0203036 A1 · Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0203036 A1
- Document ID: US20030203036A1
- Status: Published application
- Kind: A1
- Application number: 10/403,548
- Filed: 2003-03-31
- Published: 2003-10-30
- Earliest claimed: 2000-03-17
- Inventors: Marc S. Gordon; Andrew Clark; Thomas K. Brewer
- Web page: https://patentgrep.com/patent/US20030203036A1

## CPC

- A61K 9/0075: {for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles}
- A61K 9/1611: {Inorganic compounds}
- A61K 9/1623: {Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules}
- A61K 31/12: Ketones
- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K 31/355: Tocopherols, e.g. vitamin E
- A61K 31/557: Eicosanoids, e.g. leukotrienes {or prostaglandins}
- A61K 31/56: Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K 31/573: substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A61K 31/59: Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K 31/7012: Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid (gluconic acid A61K31/191; ascorbic acid A61K31/375)
- A61K 31/715: Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Methods for preparing dry powders having hydrophobic and hydrophilic components comprise combining solutions of the components and spray drying them simultaneously in a spray dryer. The hydrophilic and hydrophobic component are separately dissolved in separate solvents and directed simultaneously through a nozzle, usually a coaxial nozzle, into the spray dryer. The method provides dry powders having relatively uniform characteristics.

## Claims

### Claim 1

A method for preparing a dry powder composition, said method comprising:
preparing an aqueous solution of a hydrophilic component;
preparing an organic solution of a hydrophobic component in an organic solvent; and
spray drying the aqueous solution and the organic solution simultaneously to form particles comprising a mixture of the hydrophilic and hydrophobic component.

### Claim 2 (depends on 1)

A method as in claim 1, wherein the hydrophilic component has a concentration in the aqueous solution from 1 mg/ml to 100 mg/ml.

### Claim 3 (depends on 2)

A method as in claim 2, wherein the hydrophobic component has a solubility of at least 0.01 mg/ml in the organic solvent.

### Claim 4 (depends on 3)

A method as in claim 3, wherein the hydrophobic component has a concentration in the range from 0.01 mg/ml to 10 mg/ml in the organic solvent.

### Claim 5 (depends on 1)

A method as in claim 1, wherein the organic solvent is selected from the group consisting of alcohols, ketones, ethers, aldehydes, hydrocarbons, and polar aprotic solvents and mixtures thereof.

### Claim 6 (depends on 1)

A method as in claim 1, wherein the aqueous solution and the organic solution are sprayed through a common nozzle.

### Claim 7 (depends on 6)

A method as in claim 6, wherein the nozzle is a coaxial spray nozzle.

### Claim 8 (depends on 1)

A method as in claim 1, wherein the hydrophobic component comprises a hydrophobic drug.

### Claim 9 (depends on 8)

A method as in claim 8, wherein the hydrophobic drug is a steroid selected from the group consisting of budesonide, testosterone, progesterone, estrogen, flunisolide, triamcinolone, beclomethasone, betamethasone, dexamethasone, fluticasone, methylprednisolone, prednisone, hydrocortisone.

### Claim 10 (depends on 8)

A method as in claim 8, wherein the hydrophobic drug comprises a peptide, a retinoid, vitamin D, vitamin E, vitamin K, precursors and derivatives of these vitamins, a prostaglandin, a leukotriene, tetrahydrocannabinol, lung surfactant lipid, an antioxidant, a hydrophobic antibiotic, and a chemotherapeutic drug.

### Claim 11 (depends on 1)

A method as in claim 1, wherein the hydrophilic component comprises an excipient for the hydrophobic drug.

### Claim 12 (depends on 11)

A method as in claim 11, wherein the hydrophilic excipient comprises a material selected from the group consisting of lactose, sodium citrate, mannitol, povidone, pectin, citric acid, sodium chloride, and mixtures thereof.

### Claim 13 (depends on 1)

A method as in claim 1, further comprising screening the spray dried particles to disrupt agglomerates.

### Claim 14 (depends on 1)

A method as in claim 1, further comprising:
measuring a single dosage of the dry powder; and
sealing the single dosage in a package.

### Claim 15 (depends on 1)

A dry powder composition prepared according to claim 1.

### Claim 16 (depends on 1)

A unit dose of a dry powder composition comprising a unit dose receptacle having a therapeutically effective amount of a dry powder composition according to claim 1.

### Claim 17 (depends on 1)

A method for aerosolizing a dry powder composition said method comprising:
providing an amount of a dry powder composition according to claim 1; and
dispersing the dry powder composition into a flowing gas stream.
